Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. (CRXTQ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CRXTQ · as of Jun 9, 2026
Key Statistics
Explore Clarus Therapeutics Holdings, Inc. Data
crxtq stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 33.3%
Competitors & Peers
crxtq competitorsCRXTQ
ALEAF
ENDP
HCLC
NVTAQ
NXNNStock Performance
Full HistoryAbout Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. is a pharmaceutical enterprise dedicated to developing and marketing oral testosterone replacement therapies across the United States. Its primary offering is JATENZ…
what is clarus therapeutics holdings, inc. · crxtq stock overview · clarus therapeutics holdings, inc. company profile · who is clarus therapeutics holdings, inc. ceo · crxtq OTC · clarus therapeutics holdings, inc. headquarters · clarus therapeutics holdings, inc. business segments
About Stock Overview & Key Data
Clarus Therapeutics Holdings, Inc. (CRXTQ) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Feb 9, 2021. As of the latest trading session, CRXTQ stock price is $0.00, with a market capitalization of $72,829. The stock has returned -99.93% over the past 12 months and -89.23% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Clarus Therapeutics Holdings, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2021, Clarus Therapeutics Holdings, Inc. reported revenue of $14.0M and net income of -$56.5M. For detailed data — including Clarus Therapeutics Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Clarus Therapeutics Holdings, Inc. (CRXTQ) stock price is $0.00. The stock is traded on OTC under the ticker symbol CRXTQ. The 52-week range is $0.00 – $3.94.